Press release - Appointments
Macomics Announces New Hires as it Expands its Macrophage-based Drug Discovery and Operations Teams
Edinburgh and Cambridge, UK, 18 July 2022 - Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has made three new appointments to its scientific and operations teams, to support growth and accelerate its R&D.